20 (AIDX) EPS (Basic) (2025 - 2026)
20 posted quarterly EPS (Basic) of -$0.28 for Q1 2026, down 75.0% year-on-year from -$1.12 in Q1 2025, and down 75.0% on a QoQ basis from -$0.16 in Q1 2025.
20 (AIDX) has 2 years of EPS (Basic) data on file, last reported at -$0.28 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 75.0% year-over-year to -$0.28; the trailing twelve-month figure through Mar 2026 stood at -$0.44 (changed N/A YoY), and the FY2025 full-year result was -$0.76, up 34.48% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.28, down from -$0.16 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.16 in Q1 2025 and bottomed at -$0.28 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.52 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.25 |
| 10 | 20 | - | - | 62,884.00 | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Mar 31, 2025 | -0.16 |